Biogen (BIIB) Enterprise Value (2009 - 2026)

Biogen has reported Enterprise Value for 18 years, with the latest figure at $30.6 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 95.72% year-over-year to $30.6 billion in Q2 2026; TTM through Jun 2026 was $30.6 billion, a 95.72% increase from a year earlier, with the FY2025 full-year figure at $22.0 billion, up 10.54% from the prior year.
• Enterprise Value was $30.6 billion for Q2 2026 at Biogen, up from $22.8 billion in the prior quarter.
• The five-year high for Enterprise Value was $36.4 billion in Q4 2023, with the low at $15.7 billion in Q2 2025.
• Average Enterprise Value over 5 years is $27.5 billion, with a median of $28.7 billion recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Enterprise Value plunged 50.86% in 2025, then surged 95.72% in 2026.
• Over 5 years, Enterprise Value stood at $35.0 billion in 2022, then climbed by 4.21% to $36.4 billion in 2023, then sank by 45.34% to $19.9 billion in 2024, then advanced by 10.54% to $22.0 billion in 2025, then soared by 39.14% to $30.6 billion in 2026.
• The last three Enterprise Value figures came in at $30.6 billion (Q2 2026), $22.8 billion (Q1 2026), and $22.0 billion (Q4 2025), per Business Quant data.